Quetiapine Fumarate
Brand name: Quetiapine Fumarate
Rank #156 of 500 drugs by total cost
$100.9M
Total Cost
3,820,737
Total Claims
$100.9M
Total Cost
68,887
Prescribers
$26
Cost per Claim
473,408
Beneficiaries
5,053,785
30-Day Fills
$1,465
Avg Cost/Provider
55
Avg Claims/Provider
About Quetiapine Fumarate
Quetiapine Fumarate (sold as Quetiapine Fumarate) was prescribed 3,820,737 times by 68,887 Medicare Part D providers in 2023, costing the program $100.9M. At $26 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 153 | Pen Needle, Diabetic (Ultra-Fine Mini Pen Needle) | $105.0M | 1,305,150 |
| 154 | Divalproex Sodium (Divalproex Sodium) | $103.4M | 1,921,840 |
| 155 | Nilotinib Hcl (Tasigna) | $100.9M | 6,308 |
| 156 | Quetiapine Fumarate (Quetiapine Fumarate) | $100.9M | 3,820,737 |
| 157 | Ubrogepant (Ubrelvy) | $100.6M | 75,781 |
| 158 | Darunavir/Cobicistat (Prezcobix) | $99.7M | 38,374 |
| 159 | Tocilizumab (Actemra) | $99.5M | 24,891 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology